Cargando…
Percutaneous cryoablation for tuberous sclerosis-associated renal angiomyolipoma with neoadjuvant mTOR inhibition
BACKGROUND: Renal angiomyolipomas (AMLs) are frequent in tuberous sclerosis and are responsible for a significant proportion of the morbidity in adulthood, mainly from bleeding complications, which are correlated to the size of the AMLs. We describe the case of a 19-year-old female with multiple bil...
Autores principales: | Krummel, Thierry, Garnon, Julien, Lang, Hervé, Gangi, Afshin, Hannedouche, Thierry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177726/ https://www.ncbi.nlm.nih.gov/pubmed/25258166 http://dx.doi.org/10.1186/1471-2490-14-77 |
Ejemplares similares
-
Percutaneous MR-guided prostate cancer cryoablation technical updates and literature review
por: de Marini, Pierre, et al.
Publicado: (2019) -
Treatment effect of mTOR-inhibition on tissue composition of renal angiomyolipomas in tuberous sclerosis complex (TSC)
por: Brakemeier, Susanne, et al.
Publicado: (2017) -
mTOR Inhibitors in Tuberous Sclerosis Complex
por: Curatolo, Paolo, et al.
Publicado: (2012) -
Large renal angiomyolipomas in tuberous sclerosis
por: Esson, G, et al.
Publicado: (2023) -
Raptor Preys on mTOR Imbalance in Tuberous Sclerosis
por: Ramamurthy, Aishwarya, et al.
Publicado: (2023)